Be part of the knowledge.™

Ophthalmology

36

LikeLikedUnlike

Episodes 16-30 of 55

Macular Leakage: Indicator of Vascular Stability
MinuteCE®
Macular Leakage: Indicator of Vascular Stability
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
Signs of Progress: PED as a Predictor of Disease and Outcomes
MinuteCE®
Signs of Progress: PED as a Predictor of Disease and Outcomes
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
Fluid Foundations: How Location Impacts Outcomes in nAMD
MinuteCE®
Fluid Foundations: How Location Impacts Outcomes in nAMD
- Roger A. Goldberg, MD, MBA
  Peer
- Ehsan Rahimy, MD
  Peer
1.00 program credits
Fluid Dynamics Demystified
MinuteCE®
Fluid Dynamics Demystified
- Roger A. Goldberg, MD, MBA
  Peer
- Ehsan Rahimy, MD
  Peer
1.00 program credits
Early Fluid Resolution – A Key to Long-Term Success
MinuteCE®
Early Fluid Resolution – A Key to Long-Term Success
- Roger A. Goldberg, MD, MBA
  Peer
- Ehsan Rahimy, MD
  Peer
1.00 program credits
The Durability Dilemma
MinuteCE®
The Durability Dilemma
- Roger A. Goldberg, MD, MBA
  Peer
- Ehsan Rahimy, MD
  Peer
1.00 program credits
advertisement
Real-World Adaptation of Trial Protocols
MinuteCE®
Real-World Adaptation of Trial Protocols
- Roger A. Goldberg, MD, MBA
  Peer
- Ehsan Rahimy, MD
  Peer
1.00 program credits
Predicting Durability: Where Are We Now?
MinuteCE®
Predicting Durability: Where Are We Now?
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
New Strategies for Individualizing Treatment in DME
CME/CE
New Strategies for Individualizing Treatment in DME
- Luis A. Gonzalez, MD, MPH
  Peer
- Jeremiah Brown Jr., MD, MS, FASRS
  Peer
0.25 credits
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
CME/CE
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
- Luis A. Gonzalez, MD, MPH
  Peer
- Jeremiah Brown Jr., MD, MS, FASRS
  Peer
0.25 credits
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
CME/CE Broadcast Replay
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
- Kathleen N. Moore, MD, MS, FASCO
  Peer
- Aaron Samuel Gold, OD, FAAO
  Peer
- Carlo J. Pelino, OD, FAAO
  Peer
1.00 credits
Understanding Antibody-Drug Conjugates (ADCs)
CME/CE
Understanding Antibody-Drug Conjugates (ADCs)
- Aaron Samuel Gold, OD, FAAO
  Peer
- Carlo J. Pelino, OD, FAAO
  Peer
0.25 credits
advertisement
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
CME/CE
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
- Aaron Samuel Gold, OD, FAAO
  Peer
- Timothy G. Murray, MD, MBA, FASRS
  Peer
0.25 credits
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
CME/CE
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
- Kathleen N. Moore, MD, MS, FASCO
  Peer
- Kamran M. Riaz, MD
  Peer
0.25 credits
Collaborative Care: Managing ADC-Related Ocular Toxicities
CME/CE
Collaborative Care: Managing ADC-Related Ocular Toxicities
- Kathleen N. Moore, MD, MS, FASCO
  Peer
- Carlo J. Pelino, OD, FAAO
  Peer
0.25 credits

Program Chapters

Segment Chapters

Playlist:

Recommended